COLUMBUS, Ga. and SEATTLE, Dec. 4, 2023
/PRNewswire/ -- Aflac Incorporated (NYSE: AFL), a Fortune 500
company and leading provider of supplemental health insurance in
Japan and the United States, and Trupanion, Inc.
(Nasdaq: TRUP), the leading provider of medical insurance for cats
and dogs, jointly announce Trupanion's renewal of an S-3
registration statement on December 1,
2023. This action is taken in accordance with the
Shareholder Agreement entered into between both companies on
October 26, 2020 and renews the S-3
registration statement filed on December 1,
2020.
Aflac and Trupanion reaffirm their shared commitment to the
ongoing success of the partnership. This commitment underscores
their mutual dedication to unlocking the significant, long-term
potential of the category and their belief in the products offered
by Trupanion, the largest provider of pet medical insurance in
North America.
About Aflac Incorporated
Aflac Incorporated (NYSE:
AFL), a Fortune 500 company, has helped provide financial
protection and peace of mind for more than 68 years to millions of
policyholders and customers through its subsidiaries in the U.S.
and Japan. In the U.S., Aflac is
the No. 1 provider of supplemental health insurance
products.1 In Japan,
Aflac Life Insurance Japan is the leading provider of cancer and
medical insurance in terms of policies in force. The Company takes
pride in being there for its policyholders when they need us most,
as well as being included in 2023 in the World's Most Ethical
Companies by Ethisphere for 17 consecutive years, Fortune's World's
Most Admired Companies for 22 years and Bloomberg's Gender-Equality
Index for the fourth consecutive year. In addition, the Company
became a signatory of the Principles for Responsible Investment
(PRI) in 2021 and has been included in the Dow Jones Sustainability
North America Index (2022) for nine years. To find out how to get
help with expenses health insurance doesn't cover, get to know us
at aflac.com or aflac.com/espanol. Investors may learn more about
Aflac Incorporated and the company's commitment to corporate social
responsibility and sustainability at investors.aflac.com under
"Sustainability."
1 LIMRA 2022 U.S. Supplemental Health Insurance Total
Market Report
About Trupanion
Trupanion is a leader in medical
insurance for cats and dogs throughout the United States, Canada, Europe, Puerto
Rico and Australia with
over 960,000 pets enrolled. For over two decades, Trupanion has
given pet parents peace of mind so they can focus on their pet's
recovery, not financial stress. Trupanion is committed to providing
pet parents with the highest value in pet medical insurance with
unlimited payouts for the life of their pets. With its patented
process, Trupanion is the only North American provider with the
technology to pay veterinarians directly in seconds at the time of
checkout. Trupanion is listed on NASDAQ under the symbol "TRUP".
The company was founded in 2000 and is headquartered in
Seattle, WA. Trupanion policies
are issued, in the United States,
by its wholly-owned insurance entity American Pet Insurance Company
and, in Canada, by Omega General
Insurance Company. Trupanion Australia is a partnership between
Trupanion and Hollard Insurance Company. For more information,
please visit trupanion.com.
Forward-Looking Statements
This press release
may contain forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934 relating to,among other things,
expectations, plans, prospects and financial results for Trupanion,
including, but not limited to, the success of the Aflac partnership
and ability to unlock long-term value, its expectations regarding
its ability to continue to grow its enrollments and revenue, and
otherwise execute its business plan. These forward-looking
statements are based upon the current expectations and beliefs of
Trupanion's management as of the date of this press release, and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. All forward-looking statements made in
this press release are based on information available to Trupanion
as of the date hereof, and Trupanion has no obligation to update
these forward-looking statements. In particular, the following
factors, among others, could cause results to differ materially
from those expressed or implied by such forward-looking statements:
the ability to achieve or maintain profitability and/or appropriate
levels of cash flow in future periods; the ability to keep growing
our membership base and revenue; the accuracy of assumptions used
in determining appropriate member acquisition expenditures; the
severity and frequency of claims; the ability to maintain high
retention rates; the accuracy of assumptions used in pricing
medical plan subscriptions and the ability to accurately estimate
the impact of new products or offerings on claims frequency; actual
claims expense exceeding estimates; regulatory and other
constraints on the ability to institute, or the decision to
otherwise delay, pricing modifications in response to changes in
actual or estimated claims expense; the effectiveness and statutory
or regulatory compliance of our Territory Partner model and of our
Territory Partners, veterinarians and other third parties in
recommending medical plan subscriptions to potential members; the
ability to retain existing Territory Partners and increase the
number of Territory Partners and active hospitals; compliance by us
and those referring us members with laws and regulations that apply
to our business, including the sale of a pet medical plan; the
ability to maintain the security of our data; fluctuations in the
Canadian currency exchange rate; the ability to protect our
proprietary and member information; the ability to maintain our
culture and team; the ability to maintain the requisite amount of
risk-based capital; our ability to implement and maintain effective
controls, including over financial reporting; the ability to
protect and enforce Trupanion's intellectual property rights; the
ability to successfully implement our alliance with Aflac; the
ability to continue key contractual relationships with third
parties; third-party claims including litigation and regulatory
actions; the ability to recognize benefits from investments in new
solutions and enhancements to Trupanion's technology platform and
website; and our ability to retain key personnel. For a detailed
discussion of these and other cautionary statements, please refer
to the risk factors discussed in filings with the Securities and
Exchange Commission (SEC), including but not limited to,
Trupanion's Annual Report on Form 10-K for the year ended
December 31, 2022 and any
subsequently filed reports on Forms 10-Q,10-K and 8-K. All
documents are available through the SEC's Electronic Data Gathering
Analysis and Retrieval system at https://www.sec.gov or the
Investor Relations section of Trupanion's website at
https://investors.trupanion.com.
Contacts
Trupanion Investor Relations – Laura Bainbridge,
Laura.bainbridge@trupanion.com
Aflac Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or
dyoung@aflac.com
Aflac Media contact - Ines
Gutzmer, 762.207.7601 or igutzmer@aflac.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aflac-and-trupanion-comment-on-renewed-s-3-registration-statement-filed-in-accordance-with-2020-shareholder-agreement-302004495.html
SOURCE Aflac Incorporated